Lyell Immunopharma, Inc.

Ownership Transactions Reported by 19 Insiders

Symbol
LYEL on Nasdaq
Industry
Pharmaceutical Preparations
Location
201 Haskins Way, South San Francisco, CA

Insiders trading volume in the past year

Lyell Immunopharma, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Robert Nelsen Director, 10%+ Owner $83M Jun 14, 2024
ARCH Venture Partners IX, LLC 10%+ Owner $83M Jun 21, 2021
GSK plc 10%+ Owner $69M Jun 21, 2021
Hans Edgar Bishop Director $10.7M Jun 14, 2024
Richard Klausner Director $2.16M +$94.9K +4.59% Mar 14, 2025
Cathy Friedman Director $767K Jun 14, 2024
Lynn Seely President and CEO, Director $432K +$106K +32.6% Mar 14, 2025
Charles W. Newton Chief Financial Officer $208K +$112K +116% Mar 17, 2025
Gary K. Lee Chief Scientific Officer $120K Feb 10, 2025
Sumant Ramachandra Director $115K +$115K Mar 21, 2025
Matthew Lang Chief Business Officer $114K Feb 10, 2025
Stephen J. Hill Chief Operating Officer $112K Feb 10, 2025
Otis W. Brawley Director $20K +$20K Mar 31, 2025
Tina M. Albertson Chief Medical Officer $9.23K Feb 24, 2023
Rahsaan Thompson Chief Legal Officer Feb 24, 2023
Elizabeth Homans Chief Executive Officer, Director Mar 16, 2022
Heather D. Turner Chief General Counsel Mar 16, 2022
Elizabeth G. Nabel Director Jun 14, 2024
William Jl Rieflin Director Jun 14, 2024

Recent Insider Transactions by Companies or Individuals for Lyell Immunopharma, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.